Skip to main content
. 2018 Jul 27;2(15):1807–1816. doi: 10.1182/bloodadvances.2018019224

Figure 2.

Figure 2.

Outcome comparisons for MDS-CMML and MP-CMML. Kaplan-Meier plots for OS (A) and cumulative incidence of AML (B) in treatment-naïve patients stratified by WHO 2008 and 2017 WBC count (FAB-based MP and MDS subgroups)–based subgroups.